Option chain shows key data for Serina Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Serina Therapeutics.

Serina Therapeutics (AMEX:SER) Stock, Option Chain

Serina Therapeutics

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Analyst,Woman,Working,With,Information,Database,To,Analyze,Marketing,And

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

INUV

OCUL

PRIM

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Movers

CRDO

CTNT

CTOR

FRME

GELS

JANX

KITT

OMEX

OPTT

SGBX

SHIM

SOAR

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket

Serina Therapeutics Inc

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serko Ltd

Seiren Co Ltd

Super Zero Protocol

Serve Robotics Inc

Press Releases

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Adicet Bio

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Avalo Therapeutics

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

CervoMed

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Werewolf Therapeutics, Inc. - Common Stock

Werewolf Therapeutics

ImmuCell

Immix Biopharma

Immunic

Opus Genetics

MAIA Biotechnology

Seres Therapeutics

Metagenomi

MediciNova

PMV Pharma

Renovaro

RenovoRx

Repare Therapeutics

Senti Biosciences

Sutro Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Jones Trading

Comments

Serina Therapeutics

Serina Therapeutics (SER) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell